Finland· FI-REL-REL27588
Cilest
A norgestimate and ethinylestradiol product containing norgestimate + ethinylestradiol, registered in Finland by Orifarm Oy. The same ATC class is registered in 7 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Norgestimate and ethinylestradiol is registered in 7 of 19 countries.
Countries holding a registration under ATC G03AA11 (norgestimate and ethinylestradiol), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Norgestimate and ethinylestradiol · ATC G03AA11
7 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Norgestimate + Ethinylestradiol
- Manufacturer
- Orifarm Oy
- Country
- Finland (FI)
- ATC code
- G03AA11
- ATC class
- Norgestimate and ethinylestradiol
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
31 interactions on record for norgestimate and ethinylestradiol.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Norgestimate and ethinylestradiol · interactions on record
31 records
31 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Norgestimate and ethinylestradiol in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCilest 35microgram/250microgram tabletsMawdsley-Brooks & Company Ltd
- FranceFEMI, compriméEFFIK
- CanadaTRI-CIRA 21APOTEX INC
- PolandElinZakłady Farmaceutyczne POLPHARMA S.A.
- SwitzerlandLiberelle, FilmtablettenExeltis Suisse SA
- SpainEDELSIN comprimidosJanssen-Cilag
- GermanyAmicetteAristo Pharma Gmbh (Art 57)
- IrelandCilique 250/35 microgram tabletsGedeon Richter Plc
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Belgium · Cibel
- Germany · Amicette, Lysandra
- Denmark · Amorina, Liberelle
- Spain · Edelsine
- France · Femi, Naravela
- United Kingdom (Northern Ireland) · Cilique, Lizinna
- Ireland · Cilique
- Italy · Briladona, Briladona Trifase
- Netherlands · Norgestimaat/Ethinylestradiol Xiromed
- Norway · Amorina
- Poland · Elin, Liberelle
- Portugal · Etinilestradiol + Norgestimato Leon Farma, Femi
- Sweden · Amorina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/12f58ebb-718e-4fe1-bd1d-1c454454945f GET /v1/drugs/12f58ebb-718e-4fe1-bd1d-1c454454945f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.75",
"form": "tabletti",
"route": null,
"ddd_unit": "ED",
"strength": "250 mikrog / 35 mikrog",
"atc_label": "norgestimaatti ja etinyyliestradioli",
"ma_number": "22967",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL27588",
"authorised_at": "2007-10-17"
}See everything about norgestimate and ethinylestradiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.